Monoclonal antibody successes in the clinic
暂无分享,去创建一个
Janice M Reichert | J. Reichert | Laura B Faden | Clark J Rosensweig | Matthew C Dewitz | C. Rosensweig | Matthew C. Dewitz
[1] C. Milstein,et al. Continuous cultures of fused cells secreting antibody of predefined specificity , 1975, Nature.
[2] D. Carson,et al. Human lymphocyte hybridomas and monoclonal antibodies. , 1986, Advances in immunology.
[3] C. Milstein,et al. The hybridoma revolution: an offshoot of basic research. , 1999, BioEssays : news and reviews in molecular, cellular and developmental biology.
[4] R. Lacey,et al. Monoclonal antiendotoxin agent HA-1A (Centoxin) , 1993, The Lancet.
[5] I. Kola,et al. Can the pharmaceutical industry reduce attrition rates? , 2004, Nature Reviews Drug Discovery.
[6] G. Boulianne,et al. Production of functional chimaeric mouse/human antibody , 1984, Nature.
[7] S L Morrison,et al. Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[8] Janice M Reichert,et al. Therapeutic monoclonal antibodies: trends in development and approval in the US. , 2002, Current opinion in molecular therapeutics.
[9] Janice M. Reichert,et al. Monoclonal antibodies in the clinic , 2001, Nature Biotechnology.
[10] A. Pavlou,et al. Monoclonal antibodies market , 2004, Nature Reviews Drug Discovery.
[11] P. T. Jones,et al. Replacing the complementarity-determining regions in a human antibody with those from a mouse , 1986, Nature.
[12] K. Sikora,et al. Human monoclonal antibodies , 1982, Nature.
[13] Wadih Arap,et al. Hybridoma-free generation of monoclonal antibodies , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[14] J. Bausch,et al. Monoclonal antibodies. , 1990, Bioprocess technology.